In rheumatoid arthritis (RA), anti-citrullinated protein antibodies (ACPAs) are part of the classification criteria, and both ACPA and anti-carbamylated protein (CarP) antibodies provide prognostic information.1 Studies into the ACPA and anti-CarP antibody responses offer insight into disease onset and progression. Here, PRTN3 is linked to rheumatoid arthritis.